- JP-listed companies
- Nippon Shinyaku Co.,Ltd.
- Financials
- Net income margin (%)
Nippon Shinyaku Co.,Ltd. (4516)
Market cap
¥357.7B
P/E ratio
13.1x
Nippon Shinyaku manufactures and sells pharmaceuticals and functional foods through six subsidiaries operating in Japan, the US, and China.
| Period End | Net income margin (%) | YoY (%) |
|---|---|---|
| Mar 31, 2025 | 20.3 | +16.53% |
| Mar 31, 2024 | 17.4 | +10.20% |
| Mar 31, 2023 | 15.8 | -12.90% |
| Mar 31, 2022 | 18.2 | +6.85% |
| Mar 31, 2021 | 17 | +17.41% |
| Mar 31, 2020 | 14.5 | +1.76% |
| Mar 31, 2019 | 14.2 | +11.30% |
| Mar 31, 2018 | 12.8 | +7.34% |
| Mar 31, 2017 | 11.9 | +58.04% |
| Mar 31, 2016 | 7.5 | +2.36% |
| Mar 31, 2015 | 7.4 | +2.59% |
| Mar 31, 2014 | 7.2 | +13.35% |
| Mar 31, 2013 | 6.3 | +20.27% |
| Mar 31, 2012 | 5.3 |